Yale SPORE in Lung Cancer Career Development Program

项目总结 从事肺癌研究的内科科学家和翻译研究人员的数量没有跟上 医学研究界的整体增长或我们基本知识基础的增长，导致 在越来越多的未实现的基础研究和翻译研究机会中。耶鲁大学是唯一适合于 通过我们对基础研究和翻译研究的坚定承诺，帮助重建这个基地。职业生涯 耶鲁大学肺癌孢子项目(YSILC)的开发计划(CDP)旨在为 对正在进行的努力和试图解决这一问题的新举措具有实质性意义。我们的翻译 耶鲁大学研究室(由赫布斯特博士领导)一直致力于提供早期种子资金和 在年轻研究人员的研究生涯早期向他们提供翻译支持。CDP的目标是教育 新一代研究人员致力于肺癌的转译研究。CDP有大量的 在资金和基础设施方面的机构承诺。潜在的CDP候选对象包括 有前途的初级教员，有兴趣在转化性肺癌研究或 其先前的研究一直在其他领域的知名研究人员。初级教师奖获得者将是 与肺癌研究中更成熟的研究人员配对，他们有记录在案的成功记录 辅导。通过这种方式，YSILC将促进下一代内科科学家的发展 和翻译研究人员，解决肺癌研究中最具挑战性的问题。

PROJECT SUMMARY The number of physician-scientists and translational researchers working in lung cancer has not kept pace with the overall growth of the medical research community or with the growth in our basic knowledge base, resulting in an increasing number of unrealized basic and translational research opportunities. Yale is uniquely suited to helping rebuild this base with our strong commitment to basic and translational research. The Career Development Program (CDP) in the Yale SPORE in Lung Cancer (YSILC) has been designed to contribute substantively to ongoing efforts and new initiatives attempting to address this problem. Our translational research office at Yale (led by Dr. Herbst) has been committed to providing early seed funding and translational support to young investigators early in their research careers. The goal of the CDP is to educate a new generation of investigators committed to translational research in lung cancer. The CDP has substantial institutional commitment, both in terms of funding and infrastructure. Potential CDP candidates include promising junior faculty who are interested in establishing their career in translational lung cancer research or established investigators whose previous research has been in other areas. Junior faculty awardees will be paired with more established investigators in lung cancer research with a documented record of successful mentoring. In this way, the YSILC will stimulate the development of the next generation of physician scientists and translational researchers, addressing the most challenging issues in lung cancer research.